Articles tagged with 'cedarsscience' | Cedars-Sinai Medical Center

Some soft tissue sarcomas, a rare type of cancerous tumor, are resistant to immunotherapy and chemotherapy treatment. But Cedars-Sinai Cancer investigators, in a study published in the peer-reviewed journal Nature Communications, have identified a …

Ueli Rutishauser, PhD, is professor of Neurosurgery, Neurology and Biomedical Sciences and director of Human Neurophysiology Research and the Center for Neural Science and Medicine at Cedars-Sinai. He studies the mechanisms behind learning, memory …

Cedars-Sinai investigators, faculty members and clinicians came together in Harvey Morse Auditorium on March 27 for the 12th annual Research Day, featuring keynote speaker David R. Liu, PhD, and more than 120 poster presentations.Jeffrey A. Golden, …

Cedars-Sinai and Tel Aviv Sourasky Medical Center in Israel have formed a new research collaboration aimed at advancing healthcare innovation in five select areas.  A ceremony on March 5 in Tel Aviv was led by Shlomo Melmed, MB, ChB, executive …

In 2005, Paul Pharoah, PhD, MD, and colleagues organized a meeting in Cambridge, UK, to bring together researchers from around the world studying the genetics of ovarian cancer. It led to the creation of the Ovarian Cancer Association Consortium …

A new study by Cedars-Sinai investigators found that blocking a protein called interleukin-1-beta improved cardiac dysfunction and arrythmias in Kawasaki disease, a rare illness that affects children and causes their blood vessels to swell and …

Cedars-Sinai investigators have used artificial intelligence (AI) to help computers access some of the most important and difficult-to-mine information in cancer patients’ medical records: pathology reports. Their method, described in the …

Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by investigators in the Smidt Heart Institute …

The pain experienced by hospitalized patients with inflammatory bowel disease (IBD) is routinely treated with opioid medication, but with little success in actually controlling major discomfort. Cedars-Sinai investigators developed a Proactive …

A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS. The …

New research from the Smidt Heart Institute at Cedars-Sinai found that women who developed signs of elevated blood pressure during pregnancy were more likely to have residual evidence of abnormal heart structure and function up to a decade after the …

New research from Cedars-Sinai’s Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the drug as a preventive measure …

Investigators from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai are advancing stem cell technology to treat degenerative diseases of the eye. In one recent study, they determined the optimal dose and surgical method for …

The first prospective study comparing outcomes in patients with pituitary apoplexy—sudden bleeding or death of a pituitary tumor—found that individuals managed medically fared as well as those treated surgically in the majority of cases. The …

Investigators from the Department of Neurosurgery at Cedars-Sinai have determined that exposure to polluted air could accelerate development of Alzheimer’s disease in those with genetic risk factors for the neurodegenerative condition. Their study, …

Cedars-Sinai research leaders unveiled new AI tools, provided a biobank update and shared news about a medical student exchange program at the Research Town Hall held Oct. 12 in Harvey Morse Auditorium.“These newly instated Research Town Halls are …

Latin-American parents and caregivers in L.A. County say they need trusted sources of information before vaccinating their children against COVID-19, according to a new study led by a Cedars-Sinai investigator.The findings are published in the …

A device pioneered in partnership with Cedars-Sinai to close the most common heart defect in premature babies is safe and effective, according to the results of a clinical trial recently published in the peer-reviewed Journal of Perinatology.“This …

Meeting new people, gaining new inspiration and creating new professional and personal friendships were among the outcomes of Cedars-Sinai’s celebration of its postdoctoral researchers during National Postdoc Appreciation Week, Sept. 18-22, …

A recent Cedars-Sinai study found a combination of interventions improved satisfaction among patients being treated for chronic pain and reduced high-dose opioid prescribing.The study, published in the Journal of Pain, compared patient education and …

Investigators from the Smidt Heart Institute at Cedars-Sinai have found that community-level socioeconomic disparities are associated with worse three-year survival rates for patients with degenerative mitral regurgitation who had valve repair …

A large nationwide survey of 89,000 people conducted by Cedars-Sinai investigators found the prevalence of irritable bowel syndrome (IBS) to be higher than previously reported: 6.1% compared with 4.7% to 5.3% in studies of significantly smaller …

Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the …

Investigators from Cedars-Sinai Cancer found that Black women with a low-risk form of endometrial cancer were less likely than white women with the same cancer to have a hysterectomy, and less likely to survive their cancer. The study, published in …

Two new publications from Cedars-Sinai neuroscientists are helping to advance scientific understanding of the complex molecular and cellular processes involved in Alzheimer’s disease—and the body’s innate immune mechanisms for fighting against the …

Investigators from The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, have determined that a combination of drugs that act on the immune system in distinct ways improves survival for patients with the deadliest form of …

Sex differences in the risk and manifestation of disease are increasingly being explored in the search for effective treatments. Teasing out this variable is often overlooked in complex disease genetics, according to Cedars-Sinai investigators who …

Cedars-Sinai regenerative medicine investigators have joined with colleagues from seven other regenerative medicine institutes in the Los Angeles region to form a new consortium that will share resources and maximize the impact of state funding.“The …

Throughout a dedicated career, Stephan Targan, MD, has chiseled away at a condition once considered monolithic: inflammatory bowel disease (IBD). He and his colleagues have uncovered biomarkers that are used to better classify and treat patients, …

Cedars-Sinai investigators have identified rare genetic variants that might make some young people more likely to experience sudden cardiac arrest than others—but noted a lower rate for these variants than reported in previous studies. The findings …